Position
Fidelity in Altimmune, Inc.
Back to the book · All holders of ALT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$27K$3.08 → $3.04
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 564.1K | $2.04M | — | — | — | 0.0% |
| Q1 2026 | 674K | $2.08M | $3.08 | −$299K | $338.4K | 0.0% |
| Q2 2026 | 749K | $2.28M | $3.04 | −$27K | $228K | 0.0% |